Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China · Delayed Price · Currency is CNY 52.10
-1.42 (-2.65%)
At close: Jun 12, 2026
SHA:688193 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 10.09 | -7.81 | 8.26 | 23.33 | 64.62 |
Depreciation & Amortization | 16.39 | 16.9 | 15.57 | 14.45 | 10.02 |
Other Amortization | 2.88 | 2.65 | 2 | 1.5 | 0.77 |
Loss (Gain) From Sale of Assets | 0.39 | -0.14 | 0.05 | -0.14 | -0.76 |
Asset Writedown & Restructuring Costs | -1.57 | 0.83 | 0.34 | 1.19 | 0.38 |
Loss (Gain) From Sale of Investments | -10.11 | -10.49 | -6.16 | -9.32 | -1.21 |
Provision & Write-off of Bad Debts | - | 16.83 | 0.59 | 2.92 | 1.01 |
Other Operating Activities | -11.72 | 2.82 | 0.43 | 1 | 0.76 |
Change in Accounts Receivable | 19.8 | 9.45 | 26.66 | -49 | -19.57 |
Change in Inventory | 3.91 | 2.49 | 0.05 | -10.09 | -2.8 |
Change in Accounts Payable | -5.65 | -4.13 | -21.42 | 22.32 | -9.63 |
Change in Other Net Operating Assets | -2.14 | 2.28 | -4.16 | 2.42 | 7.95 |
Operating Cash Flow | 22.41 | 24.39 | 17.19 | -4.09 | 54.44 |
Operating Cash Flow Growth | -8.12% | 41.85% | - | - | -41.21% |
Capital Expenditures | -7.07 | -10.52 | -20.39 | -21.22 | -26.48 |
Sale of Property, Plant & Equipment | 0.21 | 1.12 | 0.39 | 0.7 | 1.94 |
Investment in Securities | -180 | -323.75 | 315 | -530 | -0.13 |
Other Investing Activities | 11.07 | 11.17 | 6.92 | 8.83 | 1.21 |
Investing Cash Flow | -175.8 | -321.99 | 301.92 | -541.68 | -23.45 |
Short-Term Debt Repaid | - | - | - | - | -3.84 |
Long-Term Debt Repaid | - | -3.27 | -3.97 | -1.26 | -1.98 |
Total Debt Repaid | - | -3.27 | -3.97 | -1.26 | -5.82 |
Net Debt Issued (Repaid) | - | -3.27 | -3.97 | -1.26 | -5.82 |
Issuance of Common Stock | 2.63 | - | - | 675.69 | - |
Repurchase of Common Stock | - | -35.66 | - | - | - |
Common Dividends Paid | -9.69 | -11.71 | -5 | - | -0.05 |
Other Financing Activities | -2.48 | - | - | -27.14 | 0.91 |
Financing Cash Flow | -9.54 | -50.64 | -8.97 | 647.29 | -4.97 |
Foreign Exchange Rate Adjustments | -1.21 | 0.56 | 0.48 | -0.15 | -0.36 |
Net Cash Flow | -164.14 | -347.69 | 310.63 | 101.37 | 25.67 |
Free Cash Flow | 15.33 | 13.86 | -3.2 | -25.31 | 27.97 |
Free Cash Flow Growth | 10.60% | - | - | - | -63.71% |
Free Cash Flow Margin | 9.47% | 7.82% | -1.94% | -8.33% | 9.57% |
Free Cash Flow Per Share | 0.40 | 0.35 | -0.08 | -0.66 | 0.92 |
Cash Income Tax Paid | 17.74 | 6.9 | 7.34 | 18.84 | 17.9 |
Levered Free Cash Flow | -19.7 | 18.4 | -10.09 | -29.74 | -3.93 |
Unlevered Free Cash Flow | -19.7 | 18.59 | -9.82 | -29.51 | -3.77 |
Change in Working Capital | 16.06 | 2.8 | -3.91 | -39.03 | -21.14 |